Moreover, the divergent findings so far on the role of dimerization in KRAS4B oncogenic behavior call for approaches that most closely match conditions in cancer cells, such as growth factors and mutant/WT allele frequency, among other factors. The gene discussed is KRAS; the disease is cancer.